Active ingredients: Enoxaparin
Clexane Syringes.
Solution for injection.
Clear, colourless to pale yellow solution.
20 mg Injection: Enoxaparin sodium 20 mg (equivalent to 2,000 IU anti-Xa activity) in 0.2 mL Water for Injections
40 mg Injection: Enoxaparin sodium 40 mg (equivalent to 4,000 IU anti-Xa activity) in 0.4 mL Water for Injections
60 mg Injection: Enoxaparin sodium 60 mg (equivalent to 6,000 IU anti-Xa activity) in 0.6 mL Water for Injections
80 mg Injection: Enoxaparin sodium 80 mg (equivalent to 8,000 IU anti-Xa activity) in 0.8 mL Water for Injections
100 mg Injection: Enoxaparin sodium 100mg (equivalent to 10,000 IU anti-Xa activity) in 1.0 mL Water for Injections
For full list of excipients, see section 6.1
Enoxaparin is a LMWH with a mean molecular weight of approximately 4,500 daltons, in which the antithrombotic and anticoagulant activities of standard heparin have been dissociated. The drug substance is the sodium salt and has a high anti-Xa activity.
Water for Injections
Solution for injection in Type I glass pre-filled syringes fitted with injection needle and an automatic safety device in packs of 10.
Sanofi-aventis
One Onslow Street
Guildford
Surrey, GU1 4YS
UK
Date of first authorisation: 22 October 1990
Date of latest renewal: 8 August 2002
PL 04425/0187